vs

Side-by-side financial comparison of Identiv, Inc. (INVE) and VSEE HEALTH, INC. (VSEE). Click either name above to swap in a different company.

Identiv, Inc. is the larger business by last-quarter revenue ($6.2M vs $3.9M, roughly 1.6× VSEE HEALTH, INC.). Identiv, Inc. runs the higher net margin — -60.3% vs -200.0%, a 139.6% gap on every dollar of revenue. On growth, VSEE HEALTH, INC. posted the faster year-over-year revenue change (5.1% vs -7.9%). Identiv, Inc. produced more free cash flow last quarter ($2.8M vs $-1.9M). Over the past eight quarters, VSEE HEALTH, INC.'s revenue compounded faster (55.6% CAGR vs -3.8%).

Identiv is a publicly traded Internet of Things technology company listed on the Nasdaq stock market.

VSEE HEALTH, INC. is a US-based telehealth technology firm offering HIPAA-compliant virtual care platforms, remote consultation tools, and chronic disease management solutions. It primarily serves healthcare providers, enterprise clients and nonprofits across North America and select global markets.

INVE vs VSEE — Head-to-Head

Bigger by revenue
INVE
INVE
1.6× larger
INVE
$6.2M
$3.9M
VSEE
Growing faster (revenue YoY)
VSEE
VSEE
+13.1% gap
VSEE
5.1%
-7.9%
INVE
Higher net margin
INVE
INVE
139.6% more per $
INVE
-60.3%
-200.0%
VSEE
More free cash flow
INVE
INVE
$4.8M more FCF
INVE
$2.8M
$-1.9M
VSEE
Faster 2-yr revenue CAGR
VSEE
VSEE
Annualised
VSEE
55.6%
-3.8%
INVE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INVE
INVE
VSEE
VSEE
Revenue
$6.2M
$3.9M
Net Profit
$-3.7M
$-7.9M
Gross Margin
18.1%
46.7%
Operating Margin
-76.4%
-87.6%
Net Margin
-60.3%
-200.0%
Revenue YoY
-7.9%
5.1%
Net Profit YoY
-948.2%
-144.7%
EPS (diluted)
$-0.17
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INVE
INVE
VSEE
VSEE
Q4 25
$6.2M
$3.9M
Q3 25
$5.0M
$4.0M
Q2 25
$5.0M
$3.4M
Q1 25
$5.3M
$3.3M
Q4 24
$6.7M
$3.7M
Q3 24
$6.5M
$3.4M
Q2 24
$6.7M
$1.7M
Q1 24
$6.7M
$1.6M
Net Profit
INVE
INVE
VSEE
VSEE
Q4 25
$-3.7M
$-7.9M
Q3 25
$-3.5M
$-289.7K
Q2 25
$-6.0M
$-2.6M
Q1 25
$-4.8M
$-4.0M
Q4 24
$-355.0K
$-3.2M
Q3 24
$85.9M
$-53.9M
Q2 24
$-6.2M
$-634.1K
Q1 24
$-4.6M
$62.8K
Gross Margin
INVE
INVE
VSEE
VSEE
Q4 25
18.1%
46.7%
Q3 25
10.7%
52.1%
Q2 25
-9.4%
46.9%
Q1 25
2.5%
56.0%
Q4 24
-14.9%
63.8%
Q3 24
3.6%
83.0%
Q2 24
9.1%
45.4%
Q1 24
7.3%
76.2%
Operating Margin
INVE
INVE
VSEE
VSEE
Q4 25
-76.4%
-87.6%
Q3 25
-111.4%
-51.7%
Q2 25
-126.7%
-66.5%
Q1 25
-103.8%
-55.1%
Q4 24
-98.9%
-81.1%
Q3 24
-146.2%
-1737.8%
Q2 24
-99.7%
-54.5%
Q1 24
-76.0%
6.4%
Net Margin
INVE
INVE
VSEE
VSEE
Q4 25
-60.3%
-200.0%
Q3 25
-68.9%
-7.3%
Q2 25
-119.9%
-77.1%
Q1 25
-90.9%
-119.2%
Q4 24
-5.3%
-85.9%
Q3 24
1315.8%
-1607.5%
Q2 24
-92.2%
-37.0%
Q1 24
-68.5%
3.9%
EPS (diluted)
INVE
INVE
VSEE
VSEE
Q4 25
$-0.17
$-0.31
Q3 25
$-0.15
$-0.02
Q2 25
$-0.26
$-0.16
Q1 25
$-0.21
$-0.24
Q4 24
$0.00
$-1.96
Q3 24
$3.62
$-3.58
Q2 24
$-0.27
$-0.12
Q1 24
$-0.21
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INVE
INVE
VSEE
VSEE
Cash + ST InvestmentsLiquidity on hand
$128.6M
$5.3M
Total DebtLower is stronger
$2.7M
Stockholders' EquityBook value
$140.7M
$5.5M
Total Assets
$151.3M
$22.4M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INVE
INVE
VSEE
VSEE
Q4 25
$128.6M
$5.3M
Q3 25
$126.3M
$472.8K
Q2 25
$129.3M
$291.6K
Q1 25
$132.4M
$410.1K
Q4 24
$135.6M
$326.1K
Q3 24
$145.4M
$2.3M
Q2 24
$18.4M
$1.1M
Q1 24
$21.6M
$724
Total Debt
INVE
INVE
VSEE
VSEE
Q4 25
$2.7M
Q3 25
$3.4M
Q2 25
$3.0M
Q1 25
$2.6M
Q4 24
$1.9M
Q3 24
$1.9M
Q2 24
$2.4M
Q1 24
Stockholders' Equity
INVE
INVE
VSEE
VSEE
Q4 25
$140.7M
$5.5M
Q3 25
$143.7M
$-5.6M
Q2 25
$146.4M
$-5.7M
Q1 25
$150.5M
$-3.5M
Q4 24
$154.1M
$-18.5K
Q3 24
$156.7M
$933.1K
Q2 24
$65.1M
$53.1M
Q1 24
$70.2M
$-13.2M
Total Assets
INVE
INVE
VSEE
VSEE
Q4 25
$151.3M
$22.4M
Q3 25
$151.0M
$18.7M
Q2 25
$153.9M
$18.2M
Q1 25
$158.7M
$19.4M
Q4 24
$163.2M
$20.0M
Q3 24
$177.0M
$22.3M
Q2 24
$97.8M
$78.6M
Q1 24
$101.8M
$1.4M
Debt / Equity
INVE
INVE
VSEE
VSEE
Q4 25
0.50×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
2.08×
Q2 24
0.05×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INVE
INVE
VSEE
VSEE
Operating Cash FlowLast quarter
$3.0M
$-1.9M
Free Cash FlowOCF − Capex
$2.8M
$-1.9M
FCF MarginFCF / Revenue
45.8%
-49.2%
Capex IntensityCapex / Revenue
3.3%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M
$-3.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INVE
INVE
VSEE
VSEE
Q4 25
$3.0M
$-1.9M
Q3 25
$-2.9M
$-754.5K
Q2 25
$-3.6M
$-324.6K
Q1 25
$-3.3M
$-440.5K
Q4 24
$-5.9M
$-3.0M
Q3 24
$-7.2M
$-221.0K
Q2 24
$-993.0K
$-3.2M
Q1 24
$-1.3M
$579.3K
Free Cash Flow
INVE
INVE
VSEE
VSEE
Q4 25
$2.8M
$-1.9M
Q3 25
$-3.2M
$-761.8K
Q2 25
$-3.8M
$-328.2K
Q1 25
$-3.6M
$-452.4K
Q4 24
$-6.5M
$-3.0M
Q3 24
$-7.7M
$-226.0K
Q2 24
$-1.1M
$-3.2M
Q1 24
$-1.5M
$570.5K
FCF Margin
INVE
INVE
VSEE
VSEE
Q4 25
45.8%
-49.2%
Q3 25
-64.5%
-19.1%
Q2 25
-75.8%
-9.7%
Q1 25
-68.0%
-13.6%
Q4 24
-97.7%
-79.8%
Q3 24
-118.2%
-6.7%
Q2 24
-16.7%
-187.6%
Q1 24
-23.0%
35.2%
Capex Intensity
INVE
INVE
VSEE
VSEE
Q4 25
3.3%
0.2%
Q3 25
7.0%
0.2%
Q2 25
5.0%
0.1%
Q1 25
5.7%
0.4%
Q4 24
9.3%
0.1%
Q3 24
7.7%
0.1%
Q2 24
2.0%
2.1%
Q1 24
3.5%
0.5%
Cash Conversion
INVE
INVE
VSEE
VSEE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.08×
Q2 24
Q1 24
9.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INVE
INVE

Other$3.4M55%
Europe And Middle East$2.2M36%
Asia Pacific$575.0K9%

VSEE
VSEE

Professional Services And Other Fees$3.1M79%
Other$823.2K21%

Related Comparisons